|
|
|
| Clinical value of combined serum tumor markers in non-small cell lung cancer |
| CHEN Shuyun,GU Wengang,and YU Li. |
| Department of Clinical Laboratory,Beijing Municipal Corps Hospital of Chinese People’s Armed Police Forces, Beijing 100027,China |
|
|
|
|
Abstract Objective To study the value of combined cytokeratin fragment 19(CYFRA21-1) and neuron-specific enolase(NSE). Methods Tumor markers were detected in 88 patients with none-small cell lung cancer(USCLC),31 patients with small cell lung cancer(SCLC),94 patients with benign lung diseases as well as 92 healthy controls using Cobras e601 electrochemical luminescence immunoassay techniques and automatic biochemical analyzer. Results The CA153 and CYFRA21-1 levels were significantly higher in patients with USCLC than in those with SCLC and in benign disease and healthy groups(P<0.05).Furthermore,in the SCLC group,the NSE level was higher than that in other groups(P<0.05).The sensitivity of single CYFRA21-1 was higher in diagnosis of USCLC and so was the specificity of single NSE in diagnosis.The sensitivity of combined CA153,CYFRA21-1 and NSE were higher. Conclusions Combined CA153,CYFRA21-1 and NSE test can increase its sensitivity and accuracy in diagnosis of USCLC,thus having a greater value in its diagnosis.
|
|
Received: 18 November 2013
|
|
|
|
|
|
| [1] |
陈 竺.全国第三次死因回顾抽样调查报告[M]. 北京:中国协和医科大学出版社,2008:1-5.
|
| [6] |
Huang W W, Tsao S M. Diagnostic value of Her-2/neu, Cyfra 21-1, and carcinoembryonic antigen levels in malignant pleural effusions of lung adenocarcinoma[J]. Pathology,2010,42(3):224-228.
|
| [7] |
孙丽娟, 秦 超. CYFRA21-1、CA19-9、VEGF联合检测对非小细胞肺癌临床诊断价值的探讨[J].当代医学,2011,17(12):41-43.(2013-05-27收稿 2013-08-20修回)
|
| [2] |
韩 冰, 许崇安. 肺癌肿瘤标志物及其联合检测的临床应用研究进展[J]. 中国热带医学,2010,10(3):382-384.
|
| [3] |
Siegel R, Naishadham D. Cancer statistics [J]. CA Cancer J Clin,2012, 62(1):10-29.
|
| [4] |
Nonaka M, Kataoka D. Pre- and post-operative serum carcinoembryonic antigen in primary lung adenocarcinoma[J]. Official Journal Of The Association Of Thoracic And Cardiovascular Surgeons Of Asia,2004,10(5):281-284.
|
| [5] |
李春海. 肿瘤标志的基础与临床应用(九) [J]. 中华医学信息导报,2005,20(1):20.
|
| [6] |
Huang W W, Tsao S M. Diagnostic value of Her-2/neu, Cyfra 21-1, and carcinoembryonic antigen levels in malignant pleural effusions of lung adenocarcinoma[J]. Pathology,2010,42(3):224-228.
|
| [7] |
孙丽娟, 秦 超. CYFRA21-1、CA19-9、VEGF联合检测对非小细胞肺癌临床诊断价值的探讨[J].当代医学,2011,17(12):41-43.(2013-05-27收稿 2013-08-20修回)
|
| [1] |
. [J]. Med. J. Chin. Peop. Armed Poli. Forc., 2019, 30(8): 711-712. |
|
|
|
|
2013, Vol. 24 
